Basiorka et al. revealed that S100A9 upregulates ROS production in hematopoietic cells and activates NLRP3 inflammasomes and β-catenin, resulting in ineffective hematopoiesis and MDS clone amplification. The gene discussed is S100A9; the disease is myelodysplastic syndrome.